Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
NCT02255266 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1788
Last updated 2018-04-17
Summary
This study is conducted in Europe. The aim of this study is to investigate Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in daily Practice.
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
No treatment given.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-26
- Primary Completion
- 2015-11-16
- Completion
- 2015-11-16
Countries
- Italy
Study Locations
More Related Trials
-
Liraglutide In Overweight Patients With Type 1 Diabetes
NCT01753362 ·Status: COMPLETED ·Phase: PHASE3
-
Liraglutide in Type 1 Diabetes
NCT01722240 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
NCT02443155 ·Status: COMPLETED ·Phase: PHASE2
-
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
NCT01299012 ·Status: COMPLETED
-
52 Week Trial of Liraglutide in Type 1 Diabetes
NCT01787916 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide in Type 1 Diabetes
NCT01612468 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Diabetic Neuropathy With Liraglutide
NCT02138045 ·Status: COMPLETED ·Phase: NA
-
Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
NCT02089256 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide as add-on to Insulin in Type 1 Diabetes
NCT02092896 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
NCT03449654 ·Status: COMPLETED ·Phase: PHASE4
-
Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
NCT01499108 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
NCT04261933 ·Status: COMPLETED
-
The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
NCT02765399 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide in Newly Onset Type 1 Diabetes.
NCT01879917 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
NCT02617654 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
NCT02655770 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
NCT02403284 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
NCT02212067 ·Status: COMPLETED ·Phase: PHASE1
-
A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
NCT01212133 ·Status: COMPLETED
-
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
NCT02408705 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
NCT03555994 ·Status: COMPLETED ·Phase: PHASE2
-
The Lira Pump Trial
NCT02351232 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
NCT02473809 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
NCT05502562 ·Status: COMPLETED
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2